4 June 2023

VIVEbiotech has successfully participated in 5 international congresses in the first half of the year

VIVEbiotech has successfully participated in 5 international congresses in the first half of the year.

Read more

18 May 2023

Article in RegMedNet about lentiviral vectors development and manufacturing challenges

Natalia Elizalde was interviewed at the Phacilitate's Advanced Therapies Week that took place in Miami in January this year.

Read more

18 May 2023

VIVEbiotech collaborates with Gyros Protein Technologies in two Gyrolab Technology Seminars

Bárbara Rodríguez-Urretavizcaya, Analytical Development Scientist, has presented at two Gyrolab Technology Seminars.

Read more

10 March 2023

Video-interview by The Medicine Maker

Natalia Elizalde was video-interviewed by The Medicine Maker during Phacilitate´s Advanced Therapies Week that took place in Miami in January.

Read more

2 March 2023

Scrip reports on the predictions of VIVEbiotech

Natalia Elizalde has been included in the clinical trial section about the leading annual article series by Scrip alongside a number of leading international figures...

Read more

17 February 2023

Gurutz Linazasoro, CEO of VIVEbiotech, participates at Transfiere

Gurutz Linazasoro, CEO of VIVEbiotech and coordinator of the AseBio´s, the Spanish Bioindustry Association ´s, advanced therapies working group, participated yesterday in a round...

Read more

30 January 2023

VIVEbiotech interview on Labiotech.eu from Florida

Labiotech.eu interviewed Natalia Elizalde during Phacilitate’s Advanced Therapies Week congress that took place last week in Miami Beach, Florida.

Read more

26 January 2023

VIVEbiotech featured in a Drug Discovery World guide

Natalia Elizalde and Naiara Tejados have participated in a Drug Discovery World cell and gene therapy guide that was recently published.

Read more

9 January 2023

Article on lentiviral vector therapies in-vivo and ex-vivo in The Medicine Maker

Naiara Tejados, Head of Marketing and Technology Development, has published an article in The Medicine Maker entitled “Know Your Vectors: a 101 on Lentiviral Therapies”.

Read more

23 December 2022

Merry Christmas and Happy New Year!

All the VIVEbiotech team wishes you a very Merry Christmas and a wonderful 2023!

Read more